» Articles » PMID: 21595956

Inhibition of Interleukin-6 Trans-signaling in the Brain Facilitates Recovery from Lipopolysaccharide-induced Sickness Behavior

Overview
Publisher Biomed Central
Date 2011 May 21
PMID 21595956
Citations 58
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Interleukin (IL)-6 is produced in the brain during peripheral infection and plays an important but poorly understood role in sickness behavior. Therefore, this study investigated the capacity of soluble gp130 (sgp130), a natural inhibitor of the IL-6 trans-signaling pathway to regulate IL-6 production in microglia and neurons in vitro and its effects on lipopolysaccharide (LPS)-induced sickness behavior in vivo.

Methods: A murine microglia (BV.2) and neuronal cell line (Neuro.2A) were used to study the effects of stimulating and inhibiting the IL-6 signaling pathway in vitro. In vivo, adult (3-6 mo) BALB/c mice received an intracerebroventricular (ICV) injection of sgp130 followed by an intraperitoneal (i.p.) injection of LPS, and sickness behavior and markers of neuroinflammation were measured.

Results: Soluble gp130 attenuated IL-6- and LPS-stimulated IL-6 receptor (IL-6R) activation along with IL-6 protein release in both microglial (BV.2) and neuronal (Neuro.2A) cell types in vitro. Moreover, in vivo experiments showed that sgp130 facilitated recovery from LPS-induced sickness, and this sgp130-associated recovery was paralleled by reduced IL-6 receptor signaling, mRNA, and protein levels of IL-6 in the hippocampus.

Conclusions: Taken together, the results show that sgp130 may exert an anti-inflammatory effect on microglia and neurons by inhibiting IL-6 binding. These data indicate that sgp130 inhibits the LPS-induced IL-6 trans-signal and show IL-6 and its receptor are involved in maintaining sickness behavior.

Citing Articles

Inhibition of IL-6 trans-signaling promotes post-stroke functional recovery in a sex and dose-dependent manner.

Hall C, Nguyen D, Mendoza K, Tan C, Chauhan A J Neuroinflammation. 2025; 22(1):52.

PMID: 40011978 PMC: 11866694. DOI: 10.1186/s12974-025-03365-y.


Effect of Residue Feed on Immunity, Antioxidant Capacity, and Transcriptome in Chickens: A Study on Sanhuang Chickens.

Zhao Y, Zhao T, Zi S, Ou G, Li H Animals (Basel). 2025; 15(1.

PMID: 39795037 PMC: 11718977. DOI: 10.3390/ani15010094.


The influence of sex on neuroimmune communication, pain, and physiology.

Alexander S, Green A, Debner E, Ramos Freitas L, Abdelhadi H, Szabo-Pardi T Biol Sex Differ. 2024; 15(1):82.

PMID: 39439003 PMC: 11494817. DOI: 10.1186/s13293-024-00660-w.


Role of metabolic dysfunction and inflammation along the liver-brain axis in animal models with obesity-induced neurodegeneration.

Asimakidou E, Saipuljumri E, Lo C, Zeng J Neural Regen Res. 2024; 20(4):1069-1076.

PMID: 38989938 PMC: 11438328. DOI: 10.4103/NRR.NRR-D-23-01770.


Search in the Periphery for Potential Inflammatory Biomarkers of Dementia with Lewy Bodies and Alzheimer's Disease.

Costantini E, Carrarini C, Calisi D, De Rosa M, Simone M, Di Crosta A J Alzheimers Dis. 2024; 99(3):1147-1158.

PMID: 38759010 PMC: 11191525. DOI: 10.3233/JAD-231471.


References
1.
Krzyszton C, Sparkman N, Grant R, Buchanan J, Broussard S, Woods J . Exacerbated fatigue and motor deficits in interleukin-10-deficient mice after peripheral immune stimulation. Am J Physiol Regul Integr Comp Physiol. 2008; 295(4):R1109-14. PMC: 2576089. DOI: 10.1152/ajpregu.90302.2008. View

2.
Richwine A, Godbout J, Berg B, Chen J, Escobar J, Millard D . Improved psychomotor performance in aged mice fed diet high in antioxidants is associated with reduced ex vivo brain interleukin-6 production. Brain Behav Immun. 2005; 19(6):512-20. DOI: 10.1016/j.bbi.2004.12.005. View

3.
Ransohoff R, Perry V . Microglial physiology: unique stimuli, specialized responses. Annu Rev Immunol. 2009; 27:119-45. DOI: 10.1146/annurev.immunol.021908.132528. View

4.
Quan N . Immune-to-brain signaling: how important are the blood-brain barrier-independent pathways?. Mol Neurobiol. 2008; 37(2-3):142-52. PMC: 2780323. DOI: 10.1007/s12035-008-8026-z. View

5.
Coles B, Fielding C, Rose-John S, Scheller J, Jones S, ODonnell V . Classic interleukin-6 receptor signaling and interleukin-6 trans-signaling differentially control angiotensin II-dependent hypertension, cardiac signal transducer and activator of transcription-3 activation, and vascular hypertrophy in vivo. Am J Pathol. 2007; 171(1):315-25. PMC: 1941613. DOI: 10.2353/ajpath.2007.061078. View